St. Jude Medical Announces FDA And European CE Mark Approvals Of The IsoFlex Optim Pacing Lead

medicalnewstoday.com     May 16, 2008            

St. Jude Medical, Inc. (NYSE:STJ) announced U.S. Food and Drug Administration (FDA) and European CE Mark approvals of the IsoFlex® Optim™ pacing lead. The small-diameter lead is built on the proven IsoFlex® pacing lead platform, and features the company's exclusive Optim® insulation material.... [read full story]                

Add a comment to the article
Type the code shown

View all news articles about:

- Related Topics